Dopamine Transporter Density of the Basal Ganglia Assessed with I-123 IPT SPECT in Methamphetamine Abusers.
- Author:
Joo Ryung LEE
1
;
Byeong Cheol AHN
;
Do Hun KEWN
;
Young Ok SUNG
;
Ji Hyoung SEO
;
Jin Ho BAE
;
Shin Young JEONG
;
Sang Woo LEE
;
Jeongsoo YOO
;
Jaetae LEE
;
Dae Yoon CHI
;
Kyu Bo LEE
Author Information
1. Department of Nuclear Medicine, Kyungpook National University Hospital, Kyungpook National Unversity Medical School, Daegu, Korea. abc2000@knu.ac.kr
- Publication Type:Original Article
- Keywords:
Methamphetamine Abuser;
IPT;
Dopamine transporter;
Brain SPECT
- MeSH:
Basal Ganglia*;
Brain;
Brief Psychiatric Rating Scale;
Cocaine;
Depression;
Dopamine Plasma Membrane Transport Proteins*;
Dopamine*;
Magnetic Resonance Imaging;
Methamphetamine*;
Street Drugs;
Tomography, Emission-Computed, Single-Photon*;
Volunteers
- From:Korean Journal of Nuclear Medicine
2005;39(6):481-488
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Functional imaging of dopamine transporter (DAT) defines integrity of the dopaminergic system, and DAT is the target site of drugs of abuse such as cocaine and methamphetamine. Functional imaging the DAT may be a sensitive and selective indicator of neurotoxic change by the drug. The aim of the present study is to evaluate the clinical implications of qualitative/quantitative analyses of dopamine transporter imaging in methamphetamine abusers. MATERIALS AND METHODS: Six detoxified methamphetamine abusers (abuser group) and 4 volunteers (control group) were enrolled in this study. Brain MRI was performed in all of abuser group. Abuser group underwent psychiatric and depression assessment using brief psychiatric rating scale (BPRS) and Hamilton depression rating scale (HAMD), respectively. All of the subjects underwent I-123 IPT SPECT (IPT SPECT). IPT SPECT image was analysed with visual qualitative method and quantitative method using basal ganglia dopamine transporter (DAT) specific/non-specific binding ratio (SBR). Comparison of DAT SBR between abuser and control groups was performed. We also performed correlation tests between psychiatric and depression assessment results and DAT SBR in abuser group. RESULTS: All of abuser group showed normal MRI finding, but had residual psychiatric and depressive symptoms, and psychiatric and depressive symptom scores were exactly correlated (r=1.0, p=0.005) each other. Five of them showed abnormal finding on qualitative visual I-123 IPT SPECT. Abuser group had lower basal ganglia DAT SBR than that of control (2.38+/-0.20 vs 3.04+/-0.27, p=0.000). Psychiatric and depressive symptoms were negatively well correlated with basal ganglia DAT SBR (r=-0.908, p=0.012, r=-0.924, p=0.009). CONCLUSION: These results suggest that dopamine transporter imaging using I-123 IPT SPECT may be used to evaluate dopaminergic system of the basal ganglia and the clinical status in methamphetamine abusers.
